Skip to main content
PLOS One logoLink to PLOS One
. 2022 Nov 23;17(11):e0278089. doi: 10.1371/journal.pone.0278089

Measurement of airborne particle emission during surgical and percutaneous dilatational tracheostomy COVID-19 adapted procedures in a swine model: Experimental report and review of literature

Valentin Favier 1,2,*, Mickael Lescroart 3, Benjamin Pequignot 3, Léonie Grimmer 4, Arnaud Florentin 4,5, Patrice Gallet 6,7,8
Editor: Silvia Fiorelli9
PMCID: PMC9683587  PMID: 36417482

Abstract

Introduction

Surgical tracheostomy (ST) and Percutaneous dilatational tracheostomy (PDT) are classified as high-risk aerosol-generating procedures and might lead to healthcare workers (HCW) infection. Albeit the COVID-19 strain slightly released since the vaccination era, preventing HCW from infection remains a major economical and medical concern. To date, there is no study monitoring particle emissions during ST and PDT in a clinical setting. The aim of this study was to monitor particle emissions during ST and PDT in a swine model.

Methods

A randomized animal study on swine model with induced acute respiratory distress syndrome (ARDS) was conducted. A dedicated room with controlled airflow was used to standardize the measurements obtained using an airborne optical particle counter. 6 ST and 6 PDT were performed in 12 pigs. Airborne particles (diameter of 0.5 to 3 μm) were continuously measured; video and audio data were recorded. The emission of particles was considered as significant if the number of particles increased beyond the normal variations of baseline particle contamination determinations in the room. These significant emissions were interpreted in the light of video and audio recordings. Duration of procedures, number of expiratory pauses, technical errors and adverse events were also analyzed.

Results

10 procedures (5 ST and 5 PDT) were fully analyzable. There was no systematic aerosolization during procedures. However, in 1/5 ST and 4/5 PDT, minor leaks and some adverse events (cuff perforation in 1 ST and 1 PDT) occurred. Human factors were responsible for 1 aerosolization during 1 PDT procedure. ST duration was significantly shorter than PDT (8.6 ± 1.3 vs 15.6 ± 1.9 minutes) and required less expiratory pauses (1 vs 6.8 ± 1.2).

Conclusions

COVID-19 adaptations allow preventing for major aerosol leaks for both ST and PDT, contributing to preserving healthcare workers during COVID-19 outbreak, but failed to achieve a perfectly airtight procedure. However, with COVID-19 adaptations, PDT required more expiratory pauses and more time than ST. Human factors and adverse events may lead to aerosolization and might be more frequent in PDT.

1 Introduction

The COVID-19 outbreak has been challenging so far for the medical field. It led to an unprecedented number of patients requiring prolonged mechanical ventilation and therefore tracheostomies. Tracheostomies, as well as endotracheal intubation, are classified as aerosol-generating procedures [13], exposing healthcare workers (HCWs) to a risk of viral infection [4]. Based on previous experiences (i.e., SARS-Cov-1 [5,6]), simulation studies and expert consensus, various adaptations have been proposed for both surgical [713] and percutaneous [7,1423] tracheostomies, including suggestions of protective equipment [13,24] (Table 1). Despite many recommendations quickly issued to ensure the safety of HCWs performing tracheostomies [25,26], the safety differences between surgical tracheostomies (ST) and percutaneous dilatational tracheostomies (PDT) techniques are unknown [27]. During the Sars-CoV-1 outbreak, surgical tracheostomies were generally favored over percutaneous tracheostomies. Indeed, PDT is associated with different steps that might generate aerosol leaks (bronchoscopy, dilatation steps), while ST is thought to lead to a unique potential exposure to aerosols when entering the trachea. In a recent attempt to summarize existing evidence and provide guidance for both healthcare providers and systems, it was stated that “the likelihood of aerosol generation is increased with percutaneous tracheostomy compared with surgical approaches” [28]. However, this statement does not rely on any experimental result. Therefore, the authors recommended to “continue to do tracheostomies using the techniques and equipment with which [teams] are familiar, and confident and experienced in using.” In the USA and UK guidelines [3,29], either open surgical tracheostomy (ST) or percutaneous dilatational tracheostomy (PDT) can be performed, when using adaptations which minimize aerosolization, “based on individual institutional expertise and defined protocols”. In practice, it is difficult to determine if tracheotomies have been a source of HCWs viral infection during the COVID-19 pandemics.

Table 1. Technical adaptation of surgical (ST) and percutaneous dilatational (PDT) tracheostomy procedures to minimize aerosolization.

Covid-19 technical adaptations proposed in the literature
Both procedures • Negative pressure ICU/operative room [711,1618] or use of negative pressure enclosure [13,24]
• Patient fully paralyzed to minimize cough reflex [79,1417,19,22]
• Pushing the tube as caudally as possible and ensure hyperinflation of the tube cuff [911,1416,2223]
• Adequate pre-oxygenation of the patient to optimize ventilation pauses [9,10,13,16,17,19]
• Expert physicians required [7,14,18,2022]
ST • Electrocautery avoidance [79]
• A single expiratory pause from tracheal entry to tracheostomy tube cuff inflation [712]
• Reducing the use of suction [8]
• Use of non-fenestrated cuffed tracheostomy tube [9]
• Interruption of ventilation 30 seconds before tracheal incision [10]
• Make the smallest incision possible [11]
• Use of a vertical incision below the cricoid level [11] or classical horizontal incision [12]
PDT • Use of bronchoscopy [7,1417,22,23]
• Expiratory pauses when placing the guidewire, performing dilatation and intratracheal placement of tracheostomy tube [7,1417,22,23]

We thus hypothesized that both ST and PDT are safe for HCWs when procedures are adapted to minimize aerosol generation. If COVID-19-related adaptations were well designed, the two procedures should not lead to significant particle emission. To verify this hypothesis, this study aimed to monitor aerosol generation during ST and PDT, using COVID-19 adaptations to minimize aerosolization, in an acute respiratory distress syndrome (ARDS) swine model.

2 Materials and methods

2.1 Study design

In this physiological study, two randomized arms were compared (ST versus PDT) on a swine model to quantify aerosols generated during these procedures. Randomization was achieved before the beginning of the experiments, using the random function of Excel 2016 software (Microsoft, Redmond, Washington, USA). Each swine specimen served as its own control (baseline aerosol measurement).

2.2 Swine model

Institutional approval was obtained from the French ministry of higher education, research and innovation (n°APAFIS#26921–202008181721597, approval 2020–066). Twelve male Landrace pigs aged 3 to 5 months and weighing 55 kg to 90 kg underwent tracheostomy procedures (6 percutaneous and 6 surgical procedures). No exclusion criteria were set.

All pigs went from the same husbandry. They were housed in groups to limit their anxiety and stressed a week before procedures in same conditions with environmental enrichment (adapted toys like balls, biting ropes…). The pigs were fasted overnight, premedicated with intramuscular injection of ketamine (1.5 mg/kg) and midazolam (0.25 mg/kg) (Warner lambert, Nordic, AB Solna, Sweden) before transportation to the experiment facility. Sedation was deepened with propofol (2.5mg/kg, B Braun, Melsungen, Duitsland) via an ear vein cannula. After being placed in supine position, animals were intubated with a 7.5-mm internal diameter endotracheal tube (ETT) followed by injection of midazolam (0,3mg/kg) and cisatracurium (GlaxoSmithKline, Marly le Roy, France) infusion (bolus 0.5mg/kg). Then, pigs were connected to a ventilator with baseline settings set at a tidal volume (Vt) of 8 mL/kg, respiratory rate (RR) of 22 breaths/min, positive end-expiratory pressure (PEEP) of 5 cmH2O, and a fraction of inspired oxygen (FiO2) of 100%. The ventilator settings were then adjusted to the results of blood gas analyses performed along with the experiment. An initial rapid IV infusion of 1000 mL normal saline was given after anesthesia induction.

To simulate the worst (riskiest) conditions for HCWs, we maximized the probability of an aerosol generation by inducing an ARDS [3032].

ARDS was performed as part of another research protocol (protocol available on request): this protocol provided ventilation conditions very similar to those of COVID-19 ARDS. Briefly, surfactant depletion was induced using repeated lung lavages (30 mL/kg warm 0.9% saline solution intratracheally) until PaO2/FiO2 was below 250 mmHg, followed by 2 hours of injurious ventilation (pressure controlled ventilation) with PEEP 0 cmH2O, inspiratory pressure 40 cmH2O, RR 10 bpm, and inspiratory:expiratory time ratio 1:1).

During preliminary tests, we observed that electrocautery could generate significant particle emissions, that could be mistaken for actual leaks and might bias the particle count (Fig 1), while the cardiac arrest did not modify the measured values. Therefore, cardiac arrest was induced before each procedure using potassium chloride to avoid bleeding. Time to desaturation (i.e., SpO2 <85%) and time to regain a correct saturation (i.e. >95%) were assessed after ARDS induction, prior to cardiac arrest, and were afterwards realistically simulated during the procedures.

Fig 1. Impact of electrocautery use on particle count during a preliminary test: Preliminary data experience showing the dramatic increase in particle count after electrocautery at T = 0.

Fig 1

Hatching in the background: Intensive care ventilator on; white in the background: Intensive care ventilator off; * significant peaks.

2.3 Aerosol measurement

All procedures were performed in the same dedicated room to standardize aerosol measurements. The installation consisted in an operating table, an intensive care unit (ICU) ventilator (Dräger Evita Infinity V500, Lubeck, Germany), an optical particle counter (Met-One-3415, BeckMan Coulter, Brea, California, USA) generating a 28 L/min intake and a mobile air treatment unit (Fig 2).

Fig 2. Picture of the dedicated room and set-up for experiments 1: Optical particle counter; 2: Intensive care ventilator; 3: Mobile air treatment unit; 4: Optical particle counter sample pipe; 5: Instrument table; 6: First operator; 7: Assistant.

Fig 2

The air exchange rate was 8.8 volumes per hour, ensuring decontamination kinetic (defined as the time required for the number of particles of 0.5–1 μm to be divided by 10) of 16 minutes (Fig 3). The particulate class defined by standard NF-EN-ISO-14644-1 according to the size of the particles present in the air was ISO 7, which meets ICU requirements and enables surgical procedures to be performed in the ICU [33]. Before each procedure, the room was decontaminated for a minimum of 50 minutes (equivalent to at least three decontamination kinetics). The particle counter collected (through a specific conductive sampling tube) different size rank of particles matter in situ (apparent diameter range 0.5–1 μm; 1–3; 3–5 μm, respectively designated as 0.5; 1; and 3 μm) emitted by the swine model. Particles < 1μm—of which viral particles—are expected to present the same behavior, a different behavior than those > 1μm due to Brownian motion.

Fig 3. Particle count variations (logarithmic scale) during decontamination kinetics, set-up, baseline measurement, tracheostomy procedure and control maneuver.

Fig 3

The sequence depicted here is as short as possible. At least three decontamination periods of 16 minutes before the set-up of the experiment were required. The set-up is generating airborne particles due to the entrance of the operators in the room. Thus, another decontamination period was performed before baseline measurement. 30 minutes after the set-up (equivalent to 2 decontamination kinetics), the operators were allowed to begin the procedure. An intentional aerosol-generating maneuver was then performed to control the effectiveness of airborne particle measurement.

The pipe was positioned between the tracheostomy area and the pig’s head, near the operators’ heads (i.e., 50 cm from the surgical site, see Fig 2). This area is presumably the most hazardous area for HCWs and where the maximum number of particles is likely to be generated (from either the endotracheal tube or the tracheostomy site). Then, the operators had to wait for a decontamination period (16 minutes) and a baseline measurement (at least 10 minutes) was performed to assess the initial level of particulate contamination due to the environment (dust convection, etc.), the monitored swine model and operators (which waited in the room).

During procedures, the particle contamination was sampled every 30 seconds (14 L) to evaluate the variations of particulate matter qualitatively and quantitatively. The continuous measurement showed some variations of particle levels even after decontamination was performed, while no aerosol-generating maneuvers are performed. These baseline variations were assessed for all preliminary tests and tracheostomy experiments, to estimate the range of normal variations, due, for example, to the surgeon’s moves in the room. Baseline measurements allowed us to interpret the events occurring during the experiments. Thus, an emission of particles was considered significant if the particle level increased beyond this level, i.e., by more than 10% from the baseline for 0.5 and 1 μm particles; and more than 25% for 3 μm particles (S1 Fig), meaning that the values correspond to emission of particles from the surgical field.

After each tracheostomy, an intentional aerosol-generating maneuver [34] was performed to ensure that aerosols were properly detected (control). It consisted of an intra-tracheal suctioning through the tracheostomy tube while mechanical ventilation was running. A comprehensive illustration of particle measurements for all steps is available in Fig 3.

2.4 Tracheostomy procedures

All procedures were fully video-recorded to analyze the timeline and match surgical steps to aerosol measurements data. All procedures were performed by expert ENT surgeons with experience well beyond the learning curve [35]. Two operators, with appropriate protective equipment, were required for each procedure, as well as an operator (VF) trained by ICU staff (ML and BP) to manage mechanical ventilation.

According to guidelines, respiratory settings during the tracheostomy procedure were performed to target protective ventilation as follows: FiO2 21%, Vt 6 mL/kg, RR 25/min and inspiratory:expiratory time ratio 1:2. PEEP was adjusted on i/plateau and ii/driving pressure [36]. When circuit disconnection was required, manual expiratory pauses were performed to prevent from excessive aerosol generation [23]. The expiratory pauses were used each time a potential leak in the ventilation circuit had to be managed. It corresponds to steps described for COVID-19 tracheostomy [3,16,23]: for each insertion of the fiber-optic endoscope in the endotracheal tube; puncture and dilatation steps; cannulation; circuit disconnection. The expiratory pauses were maintained for a maximal duration of 1 minute [23], and repeated as needed, in order to mimic clinical practice under hypoxic conditions. If the step was not achieved in a minute, the procedure was paused and the tracheostomy site was sealed to allow ventilation to be restored [37]. After each expiratory pause, a minimum of 1-minute ventilation was performed as recommended preventing desaturation [3]. For both ST and PDT, thyroid notch, sternal notch, cricoid cartilage and the first and second tracheal rings were marked on the skin with a surgical pen. Cuffed, non-fenestrated tracheostomy tubes were used as recommended [29]. The tracheostomy tube placement was confirmed with end-tidal CO2 and the circuit was checked for leaks before gently removing the endotracheal tube (ETT).

2.5 Open surgical tracheostomy (ST)

A modified ST minimizing the neck incision was performed, consisting of a 2.5-cm vertical incision from the level of the cricoid cartilage. Dissection proceeded through the platysma until the midline raphe between strap muscles. Strap muscles were separated and retracted laterally exposing the thyroid gland pushed inferiorly to allow a good exposure of the cricoid and first tracheal rings. An expiratory pause was performed during the following steps: advancement of the endotracheal tube, tracheal incision (inverted U-shaped opening), gently withdrawal of the ETT, tracheostomy tube insertion, cuff inflation, and connection to the ventilator circuit. Attention was paid to minimize suction steps during the entire procedure.

2.6 Percutaneous dilatational tracheostomy (PDT)

PDT procedures were performed according to the Ciaglia technique [38], modified for COVID-19 application [16,23,37]. A 1.5-cm vertical incision was performed at the level of the second tracheal ring. A slight dissection, using finger and Kelly clamp, was performed above the thyroid gland towards the trachea. A flexible endoscope was introduced in the endotracheal tube. The tube was gently pulled out until the inferior edge of the cricoid cartilage. The puncture through the neck incision was performed under endoscopic control, with a syringe half-filled with saline serum. The catheter was advanced while continuously applying negative pressure on the syringe until air bubbles are seen, confirming intratracheal placement. Then the syringe and needle were removed, catheter in place. A digital occlusion of the catheter was ensured to minimize leaks if ventilation needed to be restored. The guide wire was inserted in the catheter, and pre-dilator then dilator were used with gentle to-and-fro movement to achieve good dilatation. The tracheostomy tube was introduced under endoscopic guidance. The introducer was then replaced by the sleeve connected to the filter, the cuff was inflated, and the tracheostomy tube connected to the circuit.

2.7 Statistical analysis

Primary outcome was the occurrence of significant aerosol emission (leak event) during the procedure steps.

Secondary outcomes were the number of leak events, the duration of the procedure, the number of expiratory pauses, and technical problems (adverse events and/or human factors). Each significant event during procedures was interpreted in the light of the video data to correlate the emission with procedure steps and/or potential surgical mistakes. Student t-test was used to compare quantitative data, which were expressed in means +/- standard deviation.

Statistical analyses were carried out only at the completion of all procedures, using SPSS 24.0 for Windows 10.

3 Results

Twelve procedures were performed and registered (6 PDT and 6 ST). Two procedures (1 ST and 1 PDT) were excluded from the analysis due to artifacts and uncontrolled baseline variations presumably related to a lack of airtightness of the experimental room (window slightly ajar), leading to non-interpretable measurements (S1 Fig).

Particle count variations of the 10 analyzable tracheostomy procedures (named PDT-1 to PDT-5 and ST-1 to ST-5) are presented in Figs 4, 5 and S2, in which significant particle emissions are highlighted. For each procedure, the control event (intentional aerosol-generating suction) was positive. Finally, significant leaks were observed in 4/5 PDT (1 peak in PDT-1; 2 peaks in PDT-2; 1 peak in PDT-3; 3 peaks in PDT-4; no peaks in PDT-5) and 1/5 ST (1 peak in ST-3). However, the mean peaks of emitted particles were lower than those observed during provoked leaks (p<0.01) using an intra-tracheal suctioning (control, see Fig 6). We only observe for ST-3 a peak slightly higher than the control leak.

Fig 4. Examples of particle count (logarithmic scale) during two percutaneous dilatational tracheostomy (PDT) procedures.

Fig 4

Hatching in the background: Intensive care ventilator on; white in the background: Intensive care ventilator off; * significant peaks related to a breach in ventilation circuit; † significant peaks related to an artifact (like dry gauze use); red star: Uneventful endotracheal tube cuff puncture. Baseline, procedure and intentional aerosol-generating maneuver (control) are shown. During PDT-3, an early cuff puncture was responsible of multiple leaks during the procedure, while no leaks occurred in PDT-5.

Fig 5. Examples of particle count (logarithmic scale) during two surgical tracheostomy procedures (ST).

Fig 5

Hatching in the background: Intensive care ventilator on; white in the background: Intensive care ventilator off; * significant peaks related to a breach in ventilation circuit; † significant peaks related to an artifact (like dry gauze use); red star: Uneventful endotracheal tube cuff puncture. Baseline, procedure and intentional aerosol-generating maneuver (control) are shown. During ST-3, a late cuff puncture was responsible of 1 leak during the procedure, while no leaks occurred in ST-4.

Fig 6. Comparison of variations on particle count induced by control leaks and significant events during the whole procedures: The significant events generate lower levels of particles than controls.

Fig 6

Mean procedure duration from incision to cannulation was 8.6 +/- 1.3 minutes for ST and 15.6 +/- 1.9 minutes for PDT (p = 0.0003). On average, PDT required 6.8 +/- 1.2 expiratory pauses versus 1 for ST (p<0.0001). The cuff was accidentally punctured (adverse event) during the first attempt of tracheal puncture in PDT-3 and led to significant particle peaks during the subsequent ventilation steps. A similar event occurred for ST-3 when entering the trachea, thus leading to a unique significant peak at the end of the procedure. For PDT-1, there was a delay in trans-tracheal catheter occlusion after the end of the expiratory pause (human error), responsible for a significant emission of particles. For PDT-2, the cannulation was associated with significant emission of particles from 0.5 μm to 3 μm. In several surgical procedures, the analysis of video data revealed the use of dry gauze pads simultaneously to the detection of particle increase. Small white dust particles coming from gauze pads are clearly visible on images may explain the rise in particle count (false positive, see S3 Fig). There was no aerosol detected after cannula fixation: thus, there were no leaks between the cannula and surrounding soft tissues in any experiment.

4 Discussion

In the context of COVID-19 outbreak, patients to HCW transmission of COVID-19 infection remained infrequent, probably due to the many procedure adaptations proposed to reduce the risk of aerosolization for both ST [11,12,20,21,39] and PDT [17,20,21,40,41] (Table 2). In particular, current guidelines aim to avoid respiratory circuit disconnection [17], and an end-expiratory pause should be performed to reduce aerosolization when a procedure step is likely to generate leaks [37]. Our study simulated procedures close to reality and demonstrates that performing both ST and PDT, with adaptations (using expiratory pauses according to guidelines in ICU settings) may not be so dangerous for HCWs, as stated by Sood et al. [42]. Indeed, there is no systematic aerosol leaks during the procedures; when present, these leaks are below or near the level of an intratracheal suctioning maneuver.

Table 2. Reports of healthcare worker contamination during COVID-19 tracheostomy procedures in the literature (reports > 30 procedures).

Authors Procedure type Covid-19 adaptation Number of procedures Number of nosocomial contaminations reported
Picetti et al. [11] ST Yes 66 0
Avilés-Jurado et al. [12] ST Yes 50 0
Angel et al. [17] PDT Yes 98 0
Krishnamoorthy et al. [20] PDT + ST Yes 143 (85 PDT + 58 ST) 0
Kwak et al. [21] PDT + ST For PDT only 148 (NS) 1*
Tetaj et al. [40] PDT Yes 133 0
Yokokawa et al. [39] ST Yes 35 0
Moizo et al. [41] PDT Yes 36 0

* One otolaryngologist involved in open tracheostomy procedures was diagnosed COVID-19 positive but the causal link was not clearly established: 5 healthcare workers of its department fell ill too but were never involved in performing tracheostomies. PDT: Percutaneous Dilatational Tracheostomy; ST: Surgical Tracheostomy; NS: Non specified.

It may be difficult to achieve a perfectly airtight procedure from the beginning to the end, even when the operator is experienced. Breaches in the circuit of ventilation may occur during the tracheal puncture, tracheal incision, or in the case of ETT cuff perforation. This underlines the importance of having a good particle clearance in the room where the procedure is carried out, whatever the procedure chosen. In a recent comparison of 124 PDT versus 77 ST in the COVID-19 context, Rovira et al. [43] found four adverse events with potential exposure of HCWs to aerosol emission during the procedures (1 cuff rupture, 2 misplacements, 1 loss of airways), all of them in the PDT group. Niroula et al. [44] reported one out of 28 patients with an occurrence of circuit disconnection during a suture placement, exposing HCWs to aerosols. During procedures, iatrogenic cuff perforation may lead to an open-air system and HCWs aerosol exposure, as seen here for ‘PDT-3.’ This risk is present for both PDT and ST, but at different steps. ETT cuff perforation might occur at the end of ST (i.e., tracheal incision), and at the beginning of PDT (i.e., tracheal puncture). As a consequence, PDT could expose HCWs to aerosol leaks during the entire procedure. Ex-vivo swine model has already been used for ST [45], PDT training [46] and aerosol quantification [47,48]. In the swine model, it is not possible to simulate all the anatomical difficulties that can be encountered during a tracheostomy and that may greatly affect the safety of the procedure. However, the swine model also offers anatomical features that may hinder the procedure and may favor adverse cuff perforation with 1/ a smaller subglottic space than humans (resulting in a more difficult positioning of the ETT before tracheal puncture) 2/ thicker neck soft tissues preventing the use of trans-illumination for deciding the ideal level of puncture; 3/ a longer neck which may hinder the optimal placement of the ETT cuff 4/ a large thymus. Difficult anatomic conditions may be present in human in real-life condition: to minimize the associated risks, it has been proposed to perform PDT with ultrasound guidance. In our model, this might have helped to prevent such adverse event [49,50], but we were not able to study it. Ultrasound guidance should probably be further encouraged for PDT in COVID patients. Nonetheless, the literature shows that ETT cuff perforation during PDT is not a rare issue and may occur in 2–12% of procedures (Table 3) [5156]. Moreover, D’ascanio et al. [10] found that the air exposure time (i.e., the time interval between deflation of the ETT cuff and connection of the cuffed tracheostomy cannula to the ventilator) was longer in PDT (21.8 ± 5.7s) than in ST (5.5 ± 1.4 s). Thus, the risk of leaks during tracheostomy seems to be slightly greater for PDT, as proposed by McGrath [28]. Operator experience is essential to avoid such adverse event [35]. As this issue is frequent at the beginning of the learning curve [16], it is recommended not to involve trainees with COVID-19 cases unnecessarily [57].

Table 3. Reports of puncture of the tracheal tube cuff during percutaneous dilatational tracheostomy procedures in the literature.

Authors Number of procedures Use of US guidance % of tracheal tube cuff puncture
Holdgaard et al. [51] 30 No 17%
Ahmed et al. [52] 117 No 2.5%
Fikkers et al. [53] 60 No 13.3% *
Guinot et al. [54] 50 Yes 12%
Pattnaik et al. [55] 300 No 4%
Khan et al. [56] 56 No 1.78%

* This % encompassed difficult puncture and/or punctured endotracheal tube.

PDT procedures are usually reputed to be shorter than surgical procedures [18,58] but, as pointed out by Riestra-Ayora et al. [18] it should be emphasized that there is a major indication bias: PDT is often reserved for patients with favorable anatomical conditions. Furthermore, procedural modifications related to COVID-19 substantially lengthen the duration of PDT procedures. Botti et al make the same observation as us: in the Covid-19 context, PDT procedures were longer than surgical tracheostomies (10–20’ vs 30–45’ in their experience). Nevertheless, another contributor of the short ST duration in our study may be that, in porcine model, the thyroid gland is smaller than in humans, allowing an infra-isthmic approach which is faster than trans-isthmic approach.

It is valuable to notice that the senior ENT surgeons are used to perform both ST and PDT in our center. They have respectively 7 and 15 years of experience in PDT and trained anesthesiologists and ENT staff to both techniques [16]. However, before the outbreak, ST was routinely performed while PDT remained a marginal indication: this may have also slightly contributed to fasten surgical procedures.

Patient instability due to ARDS is also a significant potential problem during tracheostomies, which should make a short procedure preferable. PDT is usually considered as faster than ST [27], but COVID-19 adapted PDT requires several pauses leading to longer-lasting procedures [58], and repeated interruptions of ventilation leading to potential desaturations. The decrease of alveolar ventilation shortly drives to hypoxemia in ARDS patients, which require to pause the procedure to allow reoxygenation before to resume. In the context of ARDS, desaturation episodes require careful monitoring and should be limited to as few as possible. ST, as it requires a single pause, may reduce per-procedure hypoxemia over PDT. ARDS condition, which often occurs in COVID-19 intubated patients, was reproduced to maximize the risk of particle emission (S1 Fig) and to better emulate patient instability. We were not able to directly assess SpO2 levels during procedures in our pulseless swine model nor to perfectly reproduce the stress generated among the team by these desaturations. However, in our simulation center, desaturations were simulated as realistically as possible, based on data obtained after ARDS induction and before cardiac arrest. One important other limitation is the absence of bleeding, which may also have favored ST procedures and may explain that these procedures were further accelerated. It is noteworthy that sample size (10 procedures) was too small to account for the many inadvertent events that may contribute to aerosolization in a larger sample or result in unforeseen events. In any case, many PDT steps are at risk of airway leaks, requiring repeated end-expiratory occlusions and specific actions (e.g., catheter occlusion with a finger): thus, the risk of human error (omission, communication, or synchronization problems) is likely to be increased.

Another question raised is the risk of contamination related to electrocautery use. In our model, we chose to study particle emissions without the use of electrocautery. The huge amount of particle generated by electrocautery may have hindered the detection of particles coming from the airways (Fig 1), presumably the most dangerous one. Therefore, we decided to remove this potential confounder. Yet electrocautery, mostly used for ST, is likely to induce the release of particles that might carry viruses [59]. In a swine model, with a methodology similar to ours, Berges et al. highlighted a dramatic increase in particle emissions after electrocautery (increase of about 20–40 times the baseline) [48] and this release of particles might carry viruses [59]. In a study carried on surgical smoke in laparoscopy, Bogani et al. were indeed able to detect Sars-CoV-2 RNA [60]. Yet, it is still unclear if these particles contain viable viral material and if it carries a specific risk [61]. There is no evidence of viral transmission to HCWs from surgical smoke in pandemics. In the absence of definitive evidence, we can only recommend caution in the use of electrocautery [62,63] as the contamination risk cannot be totally ruled out [64]. A recent study [65] had compared aerosol and droplet scattering during tracheal incision for PDT and ST procedures, with measurements made in the 5 s period before the tracheal incision and the 5 s period after the tracheal incision. As recommended, mechanical ventilation was stopped when incising the trachea. There were significant leaks during PDT but no leak during ST procedures.

Another limitation relies on the OPC itself as its resolution only enables detection of particles of 0.5 microns and bigger. Considering the size of SARS-CoV-2 –ranging from 0.07 μm to 0.09 μm–, the smallest aerosol particle containing SarsCov2 virus could be as small as a single virion and would be indeed much smaller than those detected by OPC. Thus, although not plausible, it remains possible that isolated leaks of smaller particles (<0.5μm) may have occurred during the procedures. Yet, it should be emphasized that contaminant aerosols generated coughing or sneezing mostly contain particles of size 1–100 microns and that the maximum SARS-CoV-2 concentrations were measured in aerosol samples with diameters of 0.25–0.5 μm and 0.5–1.0 μm [66]. It should also be remembered that the objective of the study was not to achieve a precise quantification of the number of particles emitted.

Finally, our results seem to slightly favor ST over PDT (fewer aerosol leaks and shorter procedures). However, we would like to emphasize that, when deciding for PDT or ST, the problem is not limited to the technical part of performing tracheostomy: the discussion must take into account all aspects of the problem. For instance, if ST requires transportation of the patient to an operating room, this will require several intentional disconnections from the ventilator system, and there is a risk of extubation or accidental disconnection during transport. Bedside tracheostomy in the ICU in well-ventilated negative-pressure rooms is probably to be favored if possible [67]. Some authors also advocate that the PDT technique could be more airtight during the first few days after the procedure. However, with the adaptation of ST technique, our model showed no particle emission once the cannula was fixed. Similarly, Rovira et al. [43] reported only one leak around the cannula in the ST group (1/77) versus 0 in the PDT group. Again, a good particle clearance in ICU rooms appears crucial. Most importantly, attention must be paid to the timing of tracheostomy, as the risk of transmission increases with viral load [68].

Our initial hypothesis, that the adapted procedures for covid-19 were without risk of aerosolization for healthcare workers, could not be verified. Both PDT and ST remain at risk even if the measured peaks seemed inferior or comparable to an intratracheal suctioning maneuver. It is therefore important to recall that appropriate personal protective equipment and tracheostomy timing are major factors that help to minimize the risk of nosocomial infection for healthcare workers. Nosocomial Sars-Cov-2 infections during tracheostomy procedures seem to occur rarely (Table 2) thanks to appropriate personal protective equipment (PPE)–even if there is a risk of contamination during doffing or protection removal [69]–and specific adaptations of the procedure. Our results suggest that when all steps of the procedure are well controlled, tracheostomies can be performed with minimal risk. Combined with the use of PPE and appropriate room ventilation, there is no reason to avoid conducting such procedures. It is crucial that patients do not suffer from an excess of precaution.

The COVID-19 strain slightly released since the vaccination era. However, preventing HCW from COVID19 exposure remains crucial as: 1—It prevents from sickness related absence and the consequences of a reduction in paramedical/medical human resources; 2—The staff may be composed of frailty members that could developed ARDS even after vaccination; 3—The efficacy of vaccination might vary along the years. It is also valuable to highlight that these results could be translated to other viral respiratory tract infection.

According to these results, we may assume what Botti et al. stated “If expert ENT surgeons are available, open ST might be preferred, since PDT could result in longer apnea and exposure to generated aerosols. However, authors recommend considering either open ST or PDT at the discretion of the medical staff involved in the procedure, according to their personal experience” [70].

Supporting information

S1 Fig. Normal variations of the baseline and induced by provoked leaks.

All data from percutaneous dilatational (PDT) and surgical tracheostomy (ST) procedures are shown. Mean baseline variation depends on size particles. For 0.5 and 1 μm particles, normal baseline variations were in 10% range. For 3 μm particles, normal baseline variations were in 25% range. PDT-0 and ST-0 were preliminary measures performed without acute respiratory distress syndrome (ARDS) induction. The level of particles emitted was 1–20 times higher using ARDS, which justified the systematic induction of ARDS. ST-6 and PDT-6 were excluded because of important baseline variations due to a slightly ajar window in the experiment room.

(PDF)

S2 Fig. Particle count (logarithmic scale) during remaining percutaneous dilatational (PDT) and surgical tracheostomy (ST) procedures.

Hatching in the background: Intensive care ventilator on; white in the background: Intensive care ventilator off; * significant peaks related to a breach in ventilation circuit; † significant peaks related to an artifact (like dry gauze use). Baseline, procedure and intentional aerosol-generating maneuver (control) are shown.

(PDF)

S3 Fig. Particles emitted during the use of dry gauzes (red circles) responsible of false positive peaks, as seen on video recording.

(TIF)

Acknowledgments

The authors acknowledge Marion Bernard, Vanessa Marie, Frédérique Groubatch, Annabelle Truck and Brice Mourer from the School of surgery of Nancy-Lorraine for their technical support.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

VF received funding to support a PhD thesis on simulation from November 2019 to November 2020 by the “Collège Français d’ORL et chirurgie cervico-faciale” and the Rotary International Club of Montpellier, France. The sponsors played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors have no conflict of interest to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review. PLOS ONE. 2012. Apr 26;7(4):e35797. doi: 10.1371/journal.pone.0035797 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Jackson T, Deibert D, Wyatt G, Durand-Moreau Q, Adisesh A, Khunti K, et al. Classification of aerosol-generating procedures: a rapid systematic review. BMJ Open Respiratory Research. 2020. Oct 1;7(1):e000730. doi: 10.1136/bmjresp-2020-000730 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Lamb CR, Desai NR, Angel L, Chaddha U, Sachdeva A, Sethi S, et al. Use of Tracheostomy During the COVID-19 Pandemic. Chest. 2020. Oct;158(4):1499–514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Chen W-Q, Ling W-H, Lu C-Y, Hao Y-T, Lin Z-N, Ling L, et al. Which preventive measures might protect health care workers from SARS? BMC Public Health. 2009. Mar 13;9:81. doi: 10.1186/1471-2458-9-81 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wei WI, Tuen HH, Ng RWM, Lam LK. Safe tracheostomy for patients with severe acute respiratory syndrome. Laryngoscope. 2003. Oct;113(10):1777–9. doi: 10.1097/00005537-200310000-00022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kwan A, Fok WG, Law KI, Lam SH. Tracheostomy in a patient with severe acute respiratory syndrome. Br J Anaesth. 2004. Feb;92(2):280–2. doi: 10.1093/bja/aeh035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Michetti CP, Burlew CC, Bulger EM, Davis KA, Spain DA. Performing tracheostomy during the Covid-19 pandemic: guidance and recommendations from the Critical Care and Acute Care Surgery Committees of the American Association for the Surgery of Trauma. Trauma Surg Acute Care Open. 2020. Apr 1;5(1):e000482. doi: 10.1136/tsaco-2020-000482 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Tay JK, Khoo ML-C, Loh WS. Surgical Considerations for Tracheostomy During the COVID-19 Pandemic: Lessons Learned From the Severe Acute Respiratory Syndrome Outbreak. JAMA Otolaryngol Head Neck Surg. 2020. Jun 1;146(6):517. doi: 10.1001/jamaoto.2020.0764 [DOI] [PubMed] [Google Scholar]
  • 9.Volo T, Stritoni P, Battel I, Zennaro B, Lazzari F, Bellin M, et al. Elective tracheostomy during COVID-19 outbreak: to whom, when, how? Early experience from Venice, Italy. Eur Arch Otorhinolaryngol. 2020. Jul 12;1–9. doi: 10.1007/s00405-020-06190-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.D’Ascanio L, Pandolfini M, Capalbo M, Tempesta M. Minimizing Healthcare Worker Contamination Risk During Tracheostomy. J Am Coll Surg. 2020. Aug;231(2):299–300. doi: 10.1016/j.jamcollsurg.2020.04.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Picetti E, Fornaciari A, Taccone FS, Malchiodi L, Grossi S, Lella FD, et al. Safety of bedside surgical tracheostomy during COVID-19 pandemic: A retrospective observational study. PLOS ONE. 2020. Sep 30;15(9):e0240014. doi: 10.1371/journal.pone.0240014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Avilés-Jurado FX, Prieto-Alhambra D, González-Sánchez N, de Ossó J, Arancibia C, Rojas-Lechuga MJ, et al. Timing, Complications, and Safety of Tracheotomy in Critically Ill Patients With COVID-19. JAMA Otolaryngol Head Neck Surg. 2021. Jan 1;147(1):41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Levy DA, Boey HP, Leff PD. Modified Negative Pressure Enclosure During Tracheostomy in Patients With COVID-19. Ear Nose Throat J. 2021. Feb 2;0145561321991319. doi: 10.1177/0145561321991319 [DOI] [PubMed] [Google Scholar]
  • 14.Vargas M, Russo G, Iacovazzo C, Servillo G. Modified percutaneous tracheostomy in COVID-19 critically ill patients. Head & Neck. 2020;42(7):1363–6. doi: 10.1002/hed.26276 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Zhang X, Huang Q, Niu X, Zhou T, Xie Z, Zhong Y, et al. Safe and effective management of tracheostomy in COVID-19 patients. Head & Neck. 2020;42(7):1374–81. doi: 10.1002/hed.26261 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Favier V, Kimmoun A, Gatin A, Gallet P. Percutaneous tracheostomy simulation training for ENT physicians in the treatment of COVID-19-positive patients. Eur Ann Otorhinolaryngol Head Neck Dis. 2020. Jun 10. doi: 10.1016/j.anorl.2020.06.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Angel L, Kon ZN, Chang SH, Rafeq S, Palasamudram Shekar S, Mitzman B, et al. Novel Percutaneous Tracheostomy for Critically Ill Patients With COVID-19. Ann Thorac Surg. 2020. Sep;110(3):1006–11. doi: 10.1016/j.athoracsur.2020.04.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Riestra-Ayora J, Yanes-Diaz J, Penuelas O, Molina-Quiros C, Sanz-Fernández R, Martin-Sanz E. Safety and Prognosis in Percutaneous vs Surgical Tracheostomy in 27 Patients With COVID-19. Otolaryngol Head Neck Surg. 2020. Sep 1;163(3):462–4. doi: 10.1177/0194599820931801 [DOI] [PubMed] [Google Scholar]
  • 19.Morvan J-B, Rivière D, Danguy des Déserts M, Bonfort G, Mathais Q, Pasquier P. Percutaneous dilatational tracheostomy for saturating influx of COVID-19 patients: Experience of military ENT physicians deployed in Mulhouse, France. Eur Ann Otorhinolaryngol Head Neck Dis. 2020. Sep;137(4):263–8. doi: 10.1016/j.anorl.2020.06.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Krishnamoorthy S, Polanco A, Coleman N, Prigoff J, Sturm J, Blitzer D, et al. The Safety and Efficacy of Tracheostomy in Patients Diagnosed with COVID-19: An Analysis of 143 patients at a Major NYC Medical Center. Ann Surg. 2020. Nov 17. [DOI] [PubMed] [Google Scholar]
  • 21.Kwak PE, Connors JR, Benedict PA, Timen MR, Wang B, Zhang Y, et al. Early Outcomes From Early Tracheostomy for Patients With COVID-19. JAMA Otolaryngol Head Neck Surg. Published online December 17, 2020. doi: 10.1001/jamaoto.2020.4837 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Murphy P, Holler E, Lindroth H, Laughlin M, Simons CJ, Streib EW, et al. Short-term Outcomes for Patients and Providers After Elective Tracheostomy in COVID-19–positive Patients. Journal of Surgical Research. 2021. Apr 1;260:38–45. doi: 10.1016/j.jss.2020.10.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Boujaoude Z, Madisi N, Patel B, Rachoin J-S, Dellinger RP, Abouzgheib W. Safety and Feasibility of a Novel Protocol for Percutaneous Dilatational Tracheostomy in Patients with Respiratory Failure due to COVID-19 Infection: A Single Center Experience. Pulm Med. 2021;2021:8815925. doi: 10.1155/2021/8815925 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Chow VLY, Chan JYW, Ho VWY, Pang SSY, Lee GCC, Wong MMK, et al. Tracheostomy during COVID-19 pandemic—Novel approach. Head & Neck. 2020;42(7):1367–73. doi: 10.1002/hed.26234 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Krajewska J, Krajewski W, Zub K, Zatoński T. Review of practical recommendations for otolaryngologists and head and neck surgeons during the COVID-19 pandemic. Auris Nasus Larynx. 2020. Aug;47(4):544–58. doi: 10.1016/j.anl.2020.05.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Bier-Laning C, Cramer JD, Roy S, Palmieri PA, Amin A, Añon JM, et al. Tracheostomy During the COVID-19 Pandemic: Comparison of International Perioperative Care Protocols and Practices in 26 Countries. Otolaryngol Head Neck Surg. 2020. Nov 3;194599820961985. doi: 10.1177/0194599820961985 [DOI] [PubMed] [Google Scholar]
  • 27.Susanto I. Comparing percutaneous tracheostomy with open surgical tracheostomy. BMJ. 2002. Jan 5;324(7328):3–4. doi: 10.1136/bmj.324.7328.3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.McGrath BA, Brenner MJ, Warrillow SJ, Pandian V, Arora A, Cameron TS, et al. Tracheostomy in the COVID-19 era: global and multidisciplinary guidance. The Lancet Respiratory Medicine. 2020. Jul 1;8(7):717–25. doi: 10.1016/S2213-2600(20)30230-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Takhar A, Walker A, Tricklebank S, Wyncoll D, Hart N, Jacob T, et al. Recommendation of a practical guideline for safe tracheostomy during the COVID-19 pandemic. Eur Arch Otorhinolaryngol. 2020. Apr 21;1–12. doi: 10.1007/s00405-020-05993-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Muellenbach RM, Kredel M, Zollhoefer B, Bernd Z, Johannes A, Kuestermann J, et al. Acute respiratory distress induced by repeated saline lavage provides stable experimental conditions for 24 hours in pigs. Exp Lung Res. 2009. Apr;35(3):222–33. doi: 10.1080/01902140802534975 [DOI] [PubMed] [Google Scholar]
  • 31.Johannes A, Kredel M, Zollhoefer B, Schlegel N, Von Kirschbaum C, Brederlau J, et al. Influence of apneic oxygenation and minimal tidal volumes on ventilator-associated lung injury. Minerva Anestesiol. 2014. May;80(5):526–36. [PubMed] [Google Scholar]
  • 32.Araos J, Alegria L, Garcia P, Cruces P, Soto D, Erranz B, et al. Near-Apneic Ventilation Decreases Lung Injury and Fibroproliferation in an Acute Respiratory Distress Syndrome Model with Extracorporeal Membrane Oxygenation. Am J Respir Crit Care Med. 2019. 01;199(5):603–12. doi: 10.1164/rccm.201805-0869OC [DOI] [PubMed] [Google Scholar]
  • 33.He ZR, Lin TI, Ko PJ, Tey SL, Yeh ML, Wu HY, et al. The beneficial effect of air cleanliness with ISO 14644–1 class 7 for surgical intervention in a neonatal intensive care unit: A 10-year experience. Medicine. 2018. Sep;97(36):12257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Yu H-J, Zhu X-Y, Xu S-A, Cao W-Z, Yu Y-S. Effect of Closed Suctioning on Reducing the Contamination Released into the Environment. Chin Med J (Engl). 2017. Jul 20;130(14):1745–6. doi: 10.4103/0366-6999.209892 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Massick DD, Powell DM, Price PD, Chang SL, Squires G, Forrest LA, et al. Quantification of the Learning Curve for Percutaneous Dilatational Tracheotomy. The Laryngoscope. 2000;110(2):222–222. doi: 10.1097/00005537-200002010-00007 [DOI] [PubMed] [Google Scholar]
  • 36.Mercat A, Richard J-CM, Vielle B, Jaber S, Osman D, Diehl J-L, et al. Positive End-Expiratory Pressure Setting in Adults With Acute Lung Injury and Acute Respiratory Distress Syndrome: A Randomized Controlled Trial. JAMA. 2008. Feb 13;299(6):646. doi: 10.1001/jama.299.6.646 [DOI] [PubMed] [Google Scholar]
  • 37.Papathanakos G, Andrianopoulos I, Zikou X, Papathanasiou A, Koulouras V. Tracheostomy in the COVID-19 Era: The Apneic Approach. Otolaryngol Head Neck Surg. 2020. Dec 1;163(6):1283–4. doi: 10.1177/0194599820940652 [DOI] [PubMed] [Google Scholar]
  • 38.Ciaglia P, Firsching R, Syniec C. Elective Percutaneous Dilatational Tracheostomy: A New Simple Bedside Procedure; Preliminary Report. Chest. 1985. Jun 1;87(6):715–9. [DOI] [PubMed] [Google Scholar]
  • 39.Yokokawa T, Ariizumi Y, Hiramatsu M, Kato Y, Endo K, Obata K, et al. Management of tracheostomy in COVID-19 patients: The Japanese experience. Auris Nasus Larynx. 2021. Jun;48(3):525–9. doi: 10.1016/j.anl.2021.01.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Tetaj N, Maritti M, Stazi G, Marini MC, Centanni D, Garotto G, et al. Outcomes and Timing of Bedside Percutaneous Tracheostomy of COVID-19 Patients over a Year in the Intensive Care Unit. Journal of Clinical Medicine. 2021. Jan;10(15):3335. doi: 10.3390/jcm10153335 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Moizo E, Zangrillo A, Colombo S, Leggieri C, Mucci M, Beccaria P, et al. Percutaneous tracheostomy in COVID-19 patients: a new apneic approach. Brazilian Journal of Anesthesiology (English Edition). 2021. Jul 27. doi: 10.1016/j.bjane.2021.07.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Sood RN, Dudiki N, Alape D, Maxfiel MW. Healthcare Personnel Safety During Percutaneous Tracheostomy in Patients With COVID-19: Proof-of-Concept Study. J Intensive Care Med. 2020. Dec 16;0885066620980384. doi: 10.1177/0885066620980384 [DOI] [PubMed] [Google Scholar]
  • 43.Rovira A, Tricklebank S, Surda P, Whebell S, Zhang J, Takhar A, et al. Open versus percutaneous tracheostomy in COVID-19: a multicentre comparison and recommendation for future resource utilisation. Eur Arch Otorhinolaryngol. Published online January 9,2021. doi: 10.1007/s00405-020-06597-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Niroula A, Van Nostrand KM, Khullar OV, Force S, Jaber WS, Sardi AH, et al. Percutaneous Tracheostomy With Apnea During Coronavirus Disease 2019 Era: A Protocol and Brief Report of Cases. Critical Care Explorations. 2020. May;2(5):e0134. doi: 10.1097/CCE.0000000000000134 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Deonarain AR, Harrison RV, Gordon KA, Wolter NE, Looi T, Estrada M, et al. Live porcine model for surgical training in tracheostomy and open-airway surgery. The Laryngoscope. 2020;130(8):2063–8. doi: 10.1002/lary.28309 [DOI] [PubMed] [Google Scholar]
  • 46.Fiorelli A, Carelli E, Angioletti D, Orsini A, D’Elia A, Torino A, et al. A home-made animal model in comparison with a standard manikin for teaching percutaneous dilatational tracheostomy. Interactive CardioVascular and Thoracic Surgery. 2015. Feb 1;20(2):248–53. doi: 10.1093/icvts/ivu382 [DOI] [PubMed] [Google Scholar]
  • 47.Xiao R, Workman AD, Puka E, Juang J, Naunheim MR, Song PC. Aerosolization During Common Ventilation Scenarios. Otolaryngol Head Neck Surg. 2020;163(4):702–4. doi: 10.1177/0194599820933595 [DOI] [PubMed] [Google Scholar]
  • 48.Berges AJ, Lina IA, Ospino R, Tsai H-W, Brenner MJ, Pandian V, et al. Quantifying Viral Particle Aerosolization Risk During Tracheostomy Surgery and Tracheostomy Care. JAMA Otolaryngol Head Neck Surg. 2021. Jul 22. doi: 10.1001/jamaoto.2021.1383 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Alansari M, Alotair H, Al Aseri Z, Elhoseny MA. Use of ultrasound guidance to improve the safety of percutaneous dilatational tracheostomy: a literature review. Crit Care. 2015. May 18;19:229. doi: 10.1186/s13054-015-0942-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Menegozzo CAM, Rocha MC, Utiyama EM. Performing Ultrasound-Guided Percutaneous Tracheostomy in COVID-19 Patients. J Am Coll Surg. 2021. Feb;232(2):226–7. doi: 10.1016/j.jamcollsurg.2020.11.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Holdgaard HO, Pedersen J, Jensen RH, Outzen KE, Midtgaard T, Johansen LV, et al. Percutaneous dilatational tracheostomy versus conventional surgical tracheostomy. A clinical randomised study. Acta Anaesthesiol Scand. 1998. May;42(5):545–50. doi: 10.1111/j.1399-6576.1998.tb05164.x [DOI] [PubMed] [Google Scholar]
  • 52.Ahmed R, Rady SR, Siddique JIM, Iqbal M. Percutaneous tracheostomy in critically ill patients: 24 months experience at a tertiary care hospital in United Arab Emirates. Annals of Thoracic Medicine. 2010. Jan 1;5(1):26. doi: 10.4103/1817-1737.58956 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Fikkers BG, Staatsen M, van den Hoogen FJ, van der Hoeven JG. Early and late outcome after single step dilatational tracheostomy versus the guide wire dilating forceps technique: a prospective randomized clinical trial. Intensive Care Med. 2011. Jul;37(7):1103–9. doi: 10.1007/s00134-011-2222-4 Epub 2011 Apr 12. ; PMCID: PMC3127000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Guinot P-G, Zogheib E, Petiot S, Marienne J-P, Guerin A-M, Monet P, et al. Ultrasound-guided percutaneous tracheostomy in critically ill obese patients. Crit Care. 2012. Dec 12;16(2):R40. doi: 10.1186/cc11233 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Pattnaik SK, Ray B, Sinha S. Griggs percutaneous tracheostomy without bronchoscopic guidance is a safe method: A case series of 300 patients in a tertiary care Intensive Care Unit. Indian J Crit Care Med. 2014. Dec;18(12):778–82. doi: 10.4103/0972-5229.146303 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Khan AZ, Khan A, Naseem A. Percutaneous Tracheostomy by Physician Intensivists. J Coll Physicians Surg Pak. 2018;28(3):222–5. doi: 10.29271/jcpsp.2018.03.222 [DOI] [PubMed] [Google Scholar]
  • 57.Brindle ME, Gawande A. Managing COVID-19 in Surgical Systems. Annals of Surgery. 2020. Jul;272(1):e1. doi: 10.1097/SLA.0000000000003923 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Iftikhar IH, Teng S, Schimmel M, Duran C, Sardi A, Islam S. A Network Comparative Meta-analysis of Percutaneous Dilatational Tracheostomies Using Anatomic Landmarks, Bronchoscopic, and Ultrasound Guidance Versus Open Surgical Tracheostomy. Lung. 2019;197(3):267–75. doi: 10.1007/s00408-019-00230-7 [DOI] [PubMed] [Google Scholar]
  • 59.Ulmer BC. The hazards of surgical smoke. AORN J. 2008. Apr;87(4):721–34; quiz 735–8. doi: 10.1016/j.aorn.2007.10.012 [DOI] [PubMed] [Google Scholar]
  • 60.Bogani G, Ditto A, Cecco LD, Lopez S, Guerrisi R, Piccioni F, et al. Transmission of SARS-CoV-2 in Surgical Smoke during Laparoscopy: A Prospective, Proof-of-concept Study. Journal of Minimally Invasive Gynecology. Published online December 25, 2020. doi: 10.1016/j.jmig.2020.12.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Favier V, Gallet P. The Best Option To Protect Health Care Workers From Covid-19 During Tracheostomy Is To Adapt The Procedure. JAMA oto. Accepted August 17 2021. [DOI] [PubMed] [Google Scholar]
  • 62.Mayo‐Yánez M, Calvo‐Henríquez C, Lechien JR, Fakhry N, Ayad T, Chiesa‐Estomba CM. Is the ultrasonic scalpel recommended in head and neck surgery during the COVID-19 pandemic? State-of-the-art review. Head & Neck. 2020;42(7):1657–63. doi: 10.1002/hed.26278 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Bassi M, Ruberto F, Poggi C, Diso D, Anile M, De Giacomo T, et al. Is Surgical Tracheostomy Better Than Percutaneous Tracheostomy in COVID-19–Positive Patients? Anesthesia & Analgesia. 2020. Oct;131(4):1000–5. doi: 10.1213/ANE.0000000000005100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Pavan N, Crestani A, Abrate A, Nunzio CD, Esperto F, Giannarini G, et al. Risk of Virus Contamination Through Surgical Smoke During Minimally Invasive Surgery: A Systematic Review of the Literature on a Neglected Issue Revived in the COVID-19 Pandemic Era. European Urology Focus. 2020. Sep 15;6(5):1058–69. doi: 10.1016/j.euf.2020.05.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Tüzemen G, Kaya PK. Aerosol-generating procedure; percutaneous versus surgical tracheostomy. Am J Otolaryngol. 2022. Jun;43(3):103401. doi: 10.1016/j.amjoto.2022.103401 [DOI] [PubMed] [Google Scholar]
  • 66.Liu Y, Ning Z, Chen Y, Guo M, Liu Y, Gali NK, et al. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature. 2020. Jun;582(7813):557–60. doi: 10.1038/s41586-020-2271-3 [DOI] [PubMed] [Google Scholar]
  • 67.Chiesa-Estomba CM, Lechien JR, Calvo-Henríquez C, Fakhry N, Karkos PD, Peer S, et al. Systematic review of international guidelines for tracheostomy in COVID-19 patients. Oral Oncol. 2020. Sep;108:104844. doi: 10.1016/j.oraloncology.2020.104844 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020. May;581(7809):465–9. doi: 10.1038/s41586-020-2196-x [DOI] [PubMed] [Google Scholar]
  • 69.Favier V, Grimmer L, Florentin A, Gallet P. Withdrawal of Protective Equipment for Nasolaryngoscopy May Be at Risk of Secondary Aerosolization. Otolaryngol Head Neck Surg. 2021. Feb 2;0194599821991084. doi: 10.1177/0194599821991084 [DOI] [PubMed] [Google Scholar]
  • 70.Botti C, Lusetti F, Neri T, Peroni S, Castellucci A, Salsi P, et al. Comparison of percutaneous dilatational tracheotomy versus open surgical technique in severe COVID-19: Complication rates, relative risks and benefits. Auris Nasus Larynx. 2020. Oct 28. doi: 10.1016/j.anl.2020.10.014 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Silvia Fiorelli

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

8 Sep 2022

PONE-D-22-21253Measurement of airborne particle emission during surgical and percutaneous dilatational tracheostomy COVID-19 adapted procedures in a swine modelPLOS ONE

Dear Dr. Favier,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:

Thank you for submitting this interesting manuscript.

COVID-19 adaptations  should  be described in details in the method sections

Resolution of picture should be improved.

==============================

Please submit your revised manuscript by October 8 2022. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Silvia Fiorelli

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors present a manuscript that aims to quantify aerosol generation during percutaneous tracheostomy as well as surgical tracheostomy using an optical particle counter. This topic has become of significant interesting during the COVID-19 pandemic as aerosolization of SARS-CoV-2 is thought to put the surgeon at risk of contracting COVID-19. Overall, this is a well-designed study using a porcine model of ARDS to determine the level particle generating during 5 ST and PDTs.

1. At many institution in the U.S. PDT’s are conducted by interventional pulmonary while ST are performed by ENT’s. Do the “expert ENT surgeons” routinely perform tracheostomy using both techniques? Can “beyond the learning curve” be expanded on – with an average of 10 years of experience? Or with at least ~# PDT and ST…

2. The PDT time was that much higher than ST time – is this consistent with actual surgical procedures? Can operative logs be assessed to see what a routine time to complete these procedures is for these surgeons performing a PDT and a ST from historical patient surgical logs or anesthesia records?

3. The authors frequently note various adaptations for PDT and ST to reduce aerosol generation in light of COVID-19 (Ln57-58, 71, 75, 78, etc)– these adaptations should be explicitly stated in the introduction. To highlight them for the reader a table, figure or specific paragraph maybe helpful.

4. Limitations of OPC should be discussed. Aerosol particles can be much smaller than 0.5um threshold readily detected by OPC and may limit particles that are quantified.

5. Figures (specifically the graphs) that were downloaded with the manuscript appeared low quality. The resolution made it difficult to read.

Minor:

1. Abstract Introduction: consider keeping PDT and ST in the same order in every sentence.

2. Line 73 - HCW “contamination” - is a strange way to phrase this. Later in the paper this is referred to as “nosocomial infection for health care workers” and it seems more intuitive to what the authors are talking about.

3. Ln 53 – consider changing “intensivist” to the “medical field”

4. Ln 56 – “contamination” – consider changing to “nosocomial infection”

5. Line 59 – clarify “learning societies” - relevant societies?

6. Line 107 – Is there a reference available for this protocol yet?

7. Line 133 – “thanks to a specific sample pipe” should be rephrased.

8. Ln 182 – Why was a vertical incision used for the ST? Is this recommended for COVID or is it a porcine adaptation of a typical horizontal incision.

9. Line 252 – term contamination is again used is this referring to HCW being infected? Or just getting particle on their attire.

10. Line 318 – “evacuate” consider use of “remove”

Reviewer #2: The authors have evaluated airborne particle emission during surgical and percutaneous dilatational tracheostomy using COVID-19 adaptations. I appreciate the authors’ effort to write this manuscript, but I have some points:

1- I suggest that you revise the title. At first the reader may misinterpret that you have only evaluated two tracheostomy methods for airborne particle emission.

2- Does your study add any helpful results for using in the clinical setting in this stage of the pandemic? As you know, health care workers have less concern about infection, especially after vaccination. I suggest that you write about it in the abstract and in the manuscript.

3- Please replace your pictures with high resolution ones.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Nov 23;17(11):e0278089. doi: 10.1371/journal.pone.0278089.r002

Author response to Decision Letter 0


5 Oct 2022

Academic Editor:

Thank you for submitting this interesting manuscript.

COVID-19 adaptations should be described in detail in the method sections

Resolution of picture should be improved

• Comment: We thank the academic editor for these queries. COVID-19 adaptations have been described in a new table (Table 1), but in the introduction section, as required by Reviewer #1. Picture resolution has been improved.

Reviewer 1:

The authors present a manuscript that aims to quantify aerosol generation during percutaneous tracheostomy as well as surgical tracheostomy using an optical particle counter. This topic has become of significant interesting during the COVID-19 pandemic as aerosolization of SARS-CoV-2 is thought to put the surgeon at risk of contracting COVID-19. Overall, this is a well-designed study using a porcine model of ARDS to determine the level particle generating during 5 ST and PDTs.

• Comment 1: At many institutions in the U.S. PDT’s are conducted by interventional pulmonary while ST are performed by ENT’s. Do the “expert ENT surgeons” routinely perform tracheostomy using both techniques? Can “beyond the learning curve” be expanded on – with an average of 10 years of experience? Or with at least ~# PDT and ST

Answer 1: We thank reviewer 1 for this comment and agree with this observation: this situation is not the most prevalent. In France, PDT’s are mostly conducted by interventional pulmonary and anesthesiologists. In our center, one ENT surgeon (>15y experience) was previously trained in another center to flexible bronchoscopy for routine screening for synchronous malignancies in patients with HNSCCs and learned and daily practiced the PDT technique in this center (>50 procedures during this initial period). Subsequently, this surgeon continued to perform both techniques for years (either in ICU or in OR; but as these procedures were performed in 7 different departments, it is difficult to provide accurate data). Moreover, he trained the whole ENT staff and anesthesiologists (biannual inter-university difficult airway curriculum) to the PDT technique during all this period. The other senior surgeon had 7 years of experience with PDT and was also an instructor for PDT training courses on several occasions.

We agree that the learning curve of PDT is not clearly defined in the literature. Some authors mentioned 20 procedures [ref 35] (as well as [10.1016/j.accpm.2016.07.005] for ultrasound-guided PDT) or 30 [10.1097/01.MLG.0000163744.89688.E8] procedures to achieve low complication rates. Our opinion is that this cut-off is not really sufficient, but other authors failed to demonstrate any relationship between complication occurrence and physician experience [https://pubmed.ncbi.nlm.nih.gov/11206898/]. Competence is not assessed solely on the basis of the number of procedures performed, which is why we did not insist on this debatable point. Therefore, based on these data, we wrote that “All procedures were performed by expert ENT surgeons with experience well beyond the learning curve“ (l163-164).

Still, the indications for performing PDT rather than ST in the ENT department remained minority until the Covid outbreak (<5% of procedures performed by our team): then, the lack of anesthetists and the initial recommendations of the French ENT society (advocating for PDT) have led ENT specialists to perform many PDTs as soon as anatomical conditions were suitable (one per day during the epidemic peaks).

However, we agree with reviewer 1, while ENT surgeons in our center routinely perform both techniques, before the COVID-19 outbreak, they had a greater experience with the surgical technique, and this might have also influenced the procedure duration.

This is now specified in the discussion: nevertheless, it is still clear for us that seeking for an improved protection against particle leaks lengthens the PDT procedure, especially with unstable respiratory conditions, and that this is the main reason for the difference in procedure durations (see comment#2).

To clarify this specific point, the discussion section has been revised as follows.

Revised Manuscript – Lines 304-307: “It is valuable to notice that the senior ENT surgeons are used to perform both ST and PDT in our center. They have respectively 7 and 15 years of experience in PDT and trained anesthesiologists and ENT staff to both techniques. However, before the outbreak, ST was routinely performed while PDT remained a marginal indication: this may have also slightly contributed to fasten surgical procedures.

• Comment 2: The PDT time was that much higher than ST time – is this consistent with actual surgical procedures? Can operative logs be assessed to see what a routine time to complete these procedures is for these surgeons performing a PDT and a ST from historical patient surgical logs or anesthesia records?

Answer 2: Thank you for your comment.

We are aware that these data may seem at odds with some case series outside the context of the Covid19 outbreak.

While ST may be very quick in case of emergency (ST may be performed in <2 min , which is impossible with PDT (even if this may lead to a higher rate of complications…)), routine tracheostomies in surgeries for HNSCC (comparable to usual PDT conditions: with patients already intubated, without Covid19 nor anatomical difficulties) are usually performed by an experienced ENT surgeons in 10-15 minutes (this is easily verified in the recording of the schedule of the different surgical steps in OR), which is close to that of PDT in good conditions and outside the COvid19 context. Therefore, in our opinion, outside of this context, there is no reason to favor one technique or the other solely based on operative time (If one were to seek maximum efficiency, maybe we could even advocate for PDT if surgical tracheotomies would require a transfer to the operating room).

However, we agree with reviewer#1: several series seem to show that PDT are faster: it should though be emphasized that ST is usually preferred in case of anatomical difficulties: this is a bias which usually lengthens the procedure and which contributes to making PDT seem faster than ST. This bias has been pointed out in published series [for instance Riestra-Ayora et al.18]. This is also consistent with our usual clinical practice: the overwhelming majority of ST performed for ICU patients - in normal circumstances before the outbreak - are performed on patients with unfavorable anatomical conditions. The procedure can then be considerably lengthened. This is even more the case in an academic center, where many surgical tracheotomies are performed by junior surgeons under the supervision of seniors. In the porcine model, the thyroid gland is smaller than in humans, and surgical procedures were all performed using an infra isthmic approach: it may also have helped us to achieve faster operating times.

Yet, in our experience, the main explanation of the difference between ST and PDT lies in COVID19 adaptations: to seek for a maximal protection, PDT required several expiratory pauses and subsequent ventilation compensations to prevent desaturation3 while ST required only one pause. This may have led to an increase in the duration of PDT [10]. This is consistent with our clinical experience: we did not recorded the duration of all PDT procedures performed in the ICU during the outbreak but it was clearly lengthened (PDT procedures lasted approximately 30’ in average). Similar information are provided by Botti et al. [DOI: 10.1016/j.anl.2020.10.014 ] whom we quote here: “In our experience, operation time for OST ranges from 10 to 20′, while operation time for PDT is longer, ranging from 30 to 45′. Moreover, many severe COVID-19 patients needing invasive mechanical ventilation are obese and percutaneous tracheotomy could be actually challenging to perform in these patients.”

To clarify these points, the discussion section has been revised as follows:

Revised manuscript (lines 296-303): PDT procedures are usually reputed to be shorter than surgical procedures18,58 but, as pointed out by Riestra-Ayora et al.18 it should be emphasized that there is a major indication bias: PDT is often reserved for patients with favorable anatomical conditions. Furthermore, procedural modifications related to COVID-19 substantially lengthen the duration of PDT procedures. Botti et al make the same observation as us: in the Covid-19 context, PDT procedures were longer than surgical tracheostomies (10-20’ vs 30-45’ in their experience). Nevertheless, another contributor of the short ST duration in our study may be that, in porcine model, the thyroid gland is smaller than in humans, allowing an infra-isthmic approach which is faster than trans-isthmic approach.

• Comment 3: The authors frequently note various adaptations for PDT and ST to reduce aerosol generation in light of COVID-19 (Ln57-58, 71, 75, 78, etc)– these adaptations should be explicitly stated in the introduction. To highlight them for the reader a table, figure or specific paragraph maybe helpful.

Answer 3: We added these adaptations in a new table (Table 1).

Revised Manuscript – Line 656 : Table 1

• Comment 4: The Limitations of OPC should be discussed. Aerosol particles can be much smaller than 0.5um threshold readily detected by OPC and may limit particles that are quantified.

Answer 4: We thank the reviewer for this comment. Considering the size of SARS-CoV-2 - ranging from 0.07 μm to 0.09 μm -, the smallest aerosol particle containing SarsCov2 virus could be as small as a single virion and would be indeed much smaller than those detected by OPC. Yet in a study by Liu et al. (Nature. 2020;582:557–560. doi: 10.1038/s41586-020-2271-3), the maximum SARS-CoV-2 concentrations were measured in aerosol samples with diameters of 0.25–0.5 μm and 0.5–1.0 μm (the latter being detected by OPC). It should be remembered that the objective of the study was not to achieve a precise quantification of the number of particles emitted as a function of their size, but to detect potential leakage occurring during the procedure and to verify that procedural adaptations were able to limit these leakage moments. We were able to observe that the leaks were well detected, and that the quantities detected evolved in a joint and proportional way for all the sizes of particles detectable by the OPC. It seems to us implausible that leaks involving only particles smaller than 0.5 microns could have occurred during the procedures without any leakage of detectable particles larger than 0.5 microns: the majority of data suggests that size range of particles generated by coughing and sneezing by infected humans is from 1 µm to 100 µm. (Zhao et al., 2005; Han et al., 2013).Zhao, B., Zhang, Z., Li, X.T. (2005). Numerical study of the transport of droplets or particles generated by respiratory system indoors. Build. Environ. 40, 1032–1039. https://doi.org/10.1016/j.buildenv.2004.09.018 Han, Z.Y., Weng, W.G., Huang, Q.Y. (2013). Characterizations of particle size distribution of the droplets exhaled by sneeze. J. R. Soc. Interface 10, 20130560. https://doi.org/10.1098/rsif.2013.0560

However, we cannot completely rule out such a possibility: a specific paragraph was added in the text as follows:

Revised Manuscript – Line 346-354: Another limitation relies on the OPC itself as its resolution only enables detection of particles of 0.5 microns and bigger. Considering the size of SARS-CoV-2 - ranging from 0.07 μm to 0.09 μm -, the smallest aerosol particle containing SarsCov2 virus could be as small as a single virion and would be indeed much smaller than those detected by OPC. Thus, although not plausible, it remains possible that isolated leaks of smaller particles (<0.5μm) may have occurred during the procedures. Yet, it should be emphasized that contaminant aerosols generated coughing or sneezing mostly contain particles of size 1-100 microns and that the maximum SARS-CoV-2 concentrations were measured in aerosol samples with diameters of 0.25–0.5 μm and 0.5–1.0 μm66. It should also be remembered that the objective of the study was not to achieve a precise quantification of the number of particles emitted.

• Comment 5: Figures (specifically the graphs) that were downloaded with the manuscript appeared low quality. The resolution made it difficult to read.

Answer 5: We thank the reviewer for this comment. To address this problem (which mainly concerned supplementary figures 1 and 2, figures were splitted and enlarged. Please find new version of the pics in the attached files.

Concerning minor revisions:

• Comment 1: Abstract Introduction: consider keeping PDT and ST in the same order in every sentence:

Answer 1: we thank the reviewer for the accurate reading. Abbreviations have been replaced in correct order as suggested.

• Comment 2: Line 73 - HCW “contamination” - is a strange way to phrase this. Later in the paper this is referred to as “nosocomial infection for health care workers” and it seems more intuitive to what the authors are talking about.

Answer 2: Correction has been made as follow to clarify : “In practice, it is difficult to determine if tracheotomies have been a source of HCWs viral infection during the COVID-19 pandemics.”

• Comment 3: Ln 53 – consider changing “intensivist” to the “medical field”.

Answer 3: that is true. Change is done.

• Comment 4: Ln 56 – “contamination” – consider changing to “nosocomial infection”

Answer 4: We thank the reviewer for comment. If accepted, we would prefer the term of “viral infection” as nosocomial infection rather report to patients than HCW. The change has been made as follow: Tracheostomies, as well as endotracheal intubation, are classified as aerosol-generating procedures1-3, exposing healthcare workers (HCWs) to a risk of viral infection4

• Comment 5: Line 59 – clarify “learning societies” - relevant societies?

Answer 5: the term “Learning societies” refers to academic scientific/medical associations editing guidelines in the medical field. If the term is confusing, we propose to remove the term without changing the meaning of the sentence as follow: “Despite many recommendations quickly issued by the learning societies to ensure the safety of HCWs performing tracheostomies[…].”

• Comment 6: Line 107 – Is there a reference available for this protocol yet?

Answer 6: Dear reviewer, the aim was to induce an ARDS to improve the external validity. There is no evidence in the literature that ARDS should increase aerosol emissions during tracheostomies. The protocol is mentioned in the reference number 32 and has already been published by our teams recently.

• Comment 7: Line 133 – “thanks to a specific sample pipe” should be rephrased.

Answer 7: the sentence was rephrase as follow : “The particle counter collected (through a specific conductive sampling tube) different size rank of particles matter in situ (apparent diameter range 0.5-1 µm; 1-3; 3-5 µm, respectively designated as 0.5; 1; and 3 µm) emitted by the swine model.”

• Comment 8: Ln 182 – Why was a vertical incision used for the ST? Is this recommended for COVID or is it a porcine adaptation of a typical horizontal incision.

Answer 8: Even if the horizontal incision is mainly performed by surgical teams, some techniques use a vertical 1.5-2cm incision to minimize the trachea exposure and the risk of aerosolization [10].

• Comment 9: Line 252 – term contamination is again used is this referring to HCW being infected? Or just getting particle on their attire.

Answer 9: Dear reviewer, the term specifically refers to infection transmitted by patients to HCW while providing cares. To prevent from any misunderstandings, the sentence was rephrased as follows: “patients to HCW transmission of COVID-19 infection remained infrequent”

• Comment 10: Line 318 – “evacuate” consider use of “remove”

Answer 10: that is true again. Change is done.

Reviewer 2:

The authors have evaluated airborne particle emission during surgical and percutaneous dilatational tracheostomy using COVID-19 adaptations. I appreciate the authors’ effort to write this manuscript, but I have some points:

• Comment 1: I suggest that you revise the title. At first the reader may misinterpret that you have only evaluated two tracheostomy methods for airborne particle emission.

Answer 1: the title has been revised as follows: Measurement of airborne particle emission during surgical and percutaneous dilatational tracheostomy COVID-19 adapted procedures in a swine model: experimental report and review of literature

• Comment 2: Does your study add any helpful results for using in the clinical setting in this stage of the pandemic? As you know, health care workers have less concern about infection, especially after vaccination. I suggest that you write about it in the abstract and in the manuscript

Answer 2: Dear reviewer, thank you for your comment. That is right that the COVID-19 strain slightly released since the vaccination era. However, preventing HCW from COVID19 exposure remains crucial as:

- It prevents from sickness related absence and the consequences of a reduction in paramedical/medical human resources

- The staff may be composed of frailty members that could developed ARDS even after vaccination

- This should be considered as “one more step” to prevent from COVID19 spreading in the hospital

- The efficacy of vaccination might vary along the years.

Finally, it is valuable to highlight that these results could be translated to other viral respiratory tract infection.

To address this specific comment, the discussion was adjusted as follows line 382-387: “the COVID-19 strain slightly released since the vaccination era. However, preventing HCW from COVID19 exposure remains crucial as: 1 - It prevents from sickness related absence and the consequences of a reduction in paramedical/medical human resources; 2 - The staff may be composed of frailty members that could developed ARDS even after vaccination; 3 - The efficacy of vaccination might vary along the years. It is also valuable to highlight that these results could be translated to other viral respiratory tract infection.”

And in the abstract: “Albeit the COVID19 strain slightly released since the vaccination era, preventing HCW from COVID19 infection remains a major economical and medical concern”

• Comment 3: Please replace your pictures with high resolution ones.

Answer 3: thank you for your report. Blurry pictures have been optimized.

Attachment

Submitted filename: Response to reviewers comment.docx

Decision Letter 1

Silvia Fiorelli

10 Nov 2022

Measurement of airborne particle emission during surgical and percutaneous dilatational tracheostomy COVID-19 adapted procedures in a swine model: experimental report and review of literature

PONE-D-22-21253R1

Dear Dr. Favier,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Silvia Fiorelli

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

congratulations to the authors and thanks to the reviewers for the suggestions provided which really helped improve the quality of the manuscript

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Patient's adequately addressed all comments. This will be a nice contribution to the literature and of interest for ENT's, interventional pulmonologists, and intensivists.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

Acceptance letter

Silvia Fiorelli

14 Nov 2022

PONE-D-22-21253R1

Measurement of airborne particle emission during surgical and percutaneous dilatational tracheostomy COVID-19 adapted procedures in a swine model: experimental report and review of literature

Dear Dr. Favier:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Silvia Fiorelli

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Normal variations of the baseline and induced by provoked leaks.

    All data from percutaneous dilatational (PDT) and surgical tracheostomy (ST) procedures are shown. Mean baseline variation depends on size particles. For 0.5 and 1 μm particles, normal baseline variations were in 10% range. For 3 μm particles, normal baseline variations were in 25% range. PDT-0 and ST-0 were preliminary measures performed without acute respiratory distress syndrome (ARDS) induction. The level of particles emitted was 1–20 times higher using ARDS, which justified the systematic induction of ARDS. ST-6 and PDT-6 were excluded because of important baseline variations due to a slightly ajar window in the experiment room.

    (PDF)

    S2 Fig. Particle count (logarithmic scale) during remaining percutaneous dilatational (PDT) and surgical tracheostomy (ST) procedures.

    Hatching in the background: Intensive care ventilator on; white in the background: Intensive care ventilator off; * significant peaks related to a breach in ventilation circuit; † significant peaks related to an artifact (like dry gauze use). Baseline, procedure and intentional aerosol-generating maneuver (control) are shown.

    (PDF)

    S3 Fig. Particles emitted during the use of dry gauzes (red circles) responsible of false positive peaks, as seen on video recording.

    (TIF)

    Attachment

    Submitted filename: Response to reviewers comment.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES